SamuelArthurFrankMD

PubMed

• Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
  Samuel Frank, Karen E Anderson, Hubert H Fernandez, Robert A Hauser, Daniel O Claassen
  Neurology and Therapy. 2024-12-01
• Genetic Risk Factors in Isolated Dystonia Escape Genome-Wide Association Studies.
  Björn-Hergen Laabs, Katja Lohmann, Eva-Juliane Vollstedt, Tobias Reinberger, Lisa-Marie Nuxoll
  Movement Disorders. 2024-11-01
• Sex Differences in Dystonia.
  Gamze Kilic-Berkmen, Laura M Scorr, Lucas McKay, Mehreen Thayani, Yuping Donsante
  Movement Disorders Clinical Practice. 2024-08-01

Journal Articles

• Patient-Reported Outcome Measures in Huntington Disease: Quality of Life in Neurological Disorders (Neuro-Qol) Social Functioning Measures  
  Carlozzi NE, Hahn EA, Goodnight SM, Kratz AL, Paulsen JS, Stout JC, Frank S, Miner JA, Cella D, Gershon RC, Schilling SG, Ready RE, Psychol Assess, 1/29/2017
• Deutetrabenazine: A Review in Chorea Associated with Huntington’s Disease  
  Heo Y-A and Scott LJ, Drugs, 1/27/2017
• Patient-reported Outcomes in Huntington’s Disease: Quality of Life in Neurological Disorders (Neuro-QoL) and Huntington’s Disease Health-Related Quality of Life (HDQLI...  
  Carlozzi NE, Ready RE, Frank S, Cella D, Hahn EA, Goodnight SM, Schilling SG, Boileau NR, Dayalu P, Mov Disord, 1/27/2017
• Cerebrospinal Fluid, Plasma, and Saliva in the BioFIND Study: Relationships Among Biomarkers and Parkinson’s Disease Features  
  Goldman JG, Andrews H, Amara A, Naito A, Alcalay, Shaw LM, Taylor P, Xie T, Tuite P, Henchcliffe C, Hogarth P, Frank S, MD, Saint-Hilaire M-H, Frasier M, Arnedo V, Rei..., Movement Disorders, 1/1/2017
• Safety of Converting from Tetrabenazine to Deutetrabenazine for the Treatment of Chorea  
  Huntington Study Group (Frank S first and corresponding author), JAMA Neurology, 1/1/2017
• Utilization of hospice services in a population of patients with Huntington's Disease  
  Johnson MO, Frank S, Mendlik M, Casarett D, J of Pain and Symptom Management, 1/1/2017
• Toward Monitoring Parkinson’s Through Analysis of Static Handwriting Samples: A Quantitative Analytical Framework  
  Naiqian Z, Jaeger BK, Gouldstone A, Sipahi R and Frank S, IEEE J of Biomedical and Health Informatics, 1/1/2017
• Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease  
  Huntington Study Group (Frank S, corresponding author), JAMA, 1/1/2016
• HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD)  
  Carlozzi NE, Schilling SG, Lai JS, Paulsen JS, Hahn EA, Perlmutter JS, Ross CA, Downing NR, Kratz AL, McCormack MK, Nance MA, Quaid KA, Stout JC, Gershon RC, Ready RE,..., Quality of Life Research, 1/1/2016
• New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient reported outcomes meas...  
  Carlozzi NE, Downing NR, McCormack MK, Schilling SG, Perlmutter JS, Hahn EA, Lai JS, Frank S, Quaid KA, Paulsen JS, Cella D, Goodnight SM, Miner JA, Nance MA, Quality of Life Research, 1/1/2016
• The BioFIND Study: Characteristics of a Clinically Typical Parkinson’s Disease Biomarker Cohort  
  Kang UJ, Goldman JG, Alcalay RN, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara A, Frank S, Rudolph A, Casaceli C, Andrews H, Gwinn K, Sutherland M, Kopil C, Vincent ..., Mov Dis, 1/1/2016
• Exploring Gender-Associated Socioeconomic Differences in Parkinson’s Disease  
  McInnis R, Cavanaugh W, Weinberg J, Saint-Hilaire M, Ellias S, Frank S, Hohler A, Adv Parkinson’s Disease, 1/1/2015
• Progressive Ataxia and Palatal Tremor  
  Zuzuarregui JRP, Frank S, JAMA Neurology, 1/1/2015
• Validation of Secondary Data Sources to Identify Parkinson Disease Against Clinical Diagnostic Criteria  
  Jain S, Himali J, Beiser A, Ton TGN, Kelly-Hayes M, Biggs ML, Delaney JAC, Rosano C, Seshadri S and Frank SA, Am J Epidemiol, 1/1/2015
• Study of Plasma-Derived miRNAs Mimic Differences in Huntington’s Disease Brain  
  Hoss A, Lagomarsino V, Frank S, Hadzi T, Myers R, LaTourelle J, Mov Dis, 1/1/2015
• Are Therapeutic Motivation and Having One¹s Own Doctor as Researcher Sources of Therapeutic Misconception?  
  Kim SYH, De Vries R, Parnami S, Wilson R, Kim HM, Frank S, Holloway RG, Kieburtz K, Journal of Medical Ethics, 1/22/2014
• Treatment of Huntington’s Disease  
  Frank S, Neurotherapeutics, 1/1/2014
• Temporal Course of the Tourette Syndrome Clinical Triad  
  Shprecher D, Rubenstein L, Gannon K, Frank S, Kurlan R, Tremor Other Hyperkinet Mov, 1/1/2014
• Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease  
  Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H,..., Nat Genet, 1/1/2014
• Recurrent Bell's palsy in a patient with Crohn's disease on methotrexate  
  Desalermos A, Frank S, Farraye F, Journal of Clinical Gastroenterology, 1/1/2014
• HD-PRO-TRIAD TM Validation: A Patient-reported Instrument for the Symptom Triad of Huntington's Disease  
  Carlozzi NE, Victorson D, Sung V, Beaumont JL, Cheng W, Gorin B, Duh MS, Samuelson D, Tulsky D, Gutierrez S, Nowinski CJ, Mueller A, Shen V, Frank S, Tremor Other Hyperkinet Mov (N Y), 1/1/2014
• Research Participants 'Irrational' Expectations: Common or Commonly Mismeasured?  
  Kim SYH, De Vries R, Wilson RM, Parnami S, Frank S, Kieburtz K, Holloway RG, IRB: Ethics & Human Research, 1/1/2013
• Research Participants ‘Irrational’ Expectations: Common or Commonly Mismeasured?  
  Kim SYH, De Vries R, Wilson RM, Parnami S, Frank S, Kieburtz K, Holloway RG, IRB: Ethics & Human Research, 1/1/2013
• Botulinum Toxin for Painful Focal Seizures: Theoretical Considerations and Case Report  
  Wilkenfeld A, Frank S, McCarthy D, Neurologist, 1/1/2013
• Epidemiology and Clinical Diagnosis of Parkinson’s Disease  
  Kleinman M and Frank S, PET Clin, 1/1/2013
• Join now to see all

Books/Book Chapters

• Parkinson’s Disease and Movement Disorders 
  Chapter: Huntington’s Disease. 
  Santini V and Frank SEditors: Jankovic & Tolosa.Edition 6th,2015
• A Treasure Hunt for Mama and Me: Helping Children Cope with Parental Illness. 
  Le Verrier R and Frank SNew Horizon Press2013
• Brain Aging and Degenerative Diseases of the Brain. 
  Chapter: Chapter 21. Magnetic Resonance Imaging 
  Watanabe M, Thatcher J, Kimura Y, Delalle I, Frank S, Sakai OEditors: Luca Saba.Taylor & Francis Group2013
• 5-minute Consult 
  Chapter: Huntington Disease. 
  Westwood A, Frank S2011
• 5-minute Consult 
  Chapter: Tremor. 
  Westwood A, Frank S2011
• Movement Disorders in Principles of Drug Therapy 
  Frank S and DePold-Hoher AOxford University PressEdition 2nd,2008
• Feigin and Anderson: Huntington’s Disease (Handbook of Clinical Neurology). 
  Chapter: Section 4: Experimental Therapeutics: New Symptomatic therapies for Huntington’s Disease. 
  Deb A., Testa C., Frank S.Elsevier
• Join now to see all

Abstracts/Posters

• Evaluating swallowing function in patients with Huntington Disease enrolled in the First-HD Study.
  Samuel Frank, Sarah Janicki, Daniel Claassen, David Oakes, Victor Sung, Christina Vaughan and Claudia Testa on behalf of the Huntington Study Group First-HD Investigators, International Parkinson Disease and Movement Disorder Congress, 1/22/2016
• Deutetrabenazine Effect on Total Motor Score in Patients with Huntington Disease (First-HD)
  Samuel Frank, David Stamler, Victor Sung, Daniel Claassen, Sarah Janicki, Clement Loy, Erin Furr-Stimming, David Oakes and Claudia Testa on behalf of the Huntington St..., American Academy of Neurology, Vancouver, British Columbia, Canada, 1/19/2016
• Rating Swallowing Function in Patients with Huntington Disease Enrolled in the First-HD Study.
  Daniel Claassen, Samuel Frank, David Stamler, Victor Sung, Sarah Janicki, David Oakes, Christina Vaughan and Claudia Testa on behalf of the Huntington Study Group Firs..., American Academy of Neurology, 1/18/2016
• Comparable Neuropsychiatric Safety Observed with Deutetrabenazine Treatment and Placebo in Patients with Huntington's Disease (First-HD).
  Victor Sung, Daniel Claassen, Mary Edmondson, Samuel Frank, David Oakes, David Stamler, Claudia Testa on behalf of the Huntington Study Group First-HD Investigators, American Psychiatric Association meeting, 1/14/2016
• Evaluation of patient- and clinician-reported outcomes in treatment of Huntington Disease with deutetrabenazine
  Claudia Testa, Daniel Claassen, Samuel Frank, David Oakes, David Stamler and Victor Sung on behalf of the Huntington Study Group First-HD Investigators, International Parkinson Disease and Movement Disorder Congress, 1/1/2016
• Maintenance of balance function in patients with HD treated with deutetrabenazine, as measured by Berg Balance test in First-HD.
  Daniel Claassen, Samuel Frank, David Oakes, David Stamler, Victor Sung and Claudia Testa on behalf of the Huntington Study Group First-HD Investigators, International Parkinson Disease and Movement Disorder Congress, 1/1/2016
• Utilization of hospice services in a population of patients with Huntington’s Disease.
  Mendlik M and Frank S, AAHPM & HPNA Annual Assembly, Philadelphia, PA, 1/25/2015
• Alternatives for Reducing Chorea in Huntington Disease (ARC-HD): Results from the Switch Cohort.
  Huntington Study Group (Frank S, presenter), Huntington Study Group; Movement Disorders; International Parkinson Disease and Movement Disorder Congress, 1/1/2015
• The BioFIND Study, Biomarker Discovery Cohort in Parkinson’s Disease: Design and Methodology.
  BioFIND Study Group (Frank S), American Academy of Neurology, Philadelphia, PA, 1/30/2014
• Characteristics of Parkinson’s Disease Presentation and Management: A Comparison of Caucasians and Minorities.
  Kaplan A, Saint-Hilaire M, Depold-Hohler, Ellias, Frank S, American Academy of Neurology, San Diego, CA, 1/20/2013
• Join now to see all

Lectures

• Huntington’s Disease 
  Beth Israel Deaconess Medical Center - 1/1/2018
• VMAT2 Inhibitors: The FDA Approval Process and Community Impact. 
  MGH - 1/1/2017
• An Interdisciplinary Approach to Caring for Individuals Affected by Huntington’s Disease and their Families 
  MGH - 1/1/2017
• Clinical Management of Advancing Huntington’s Disease. 
  University of Rochester, Rochester, NY - 1/1/2016
• Overview of Movement Disorders. 
  Cambridge Hospital, Cambridge, MA - 1/1/2016
• Introduction to the Neurological Exam 
  Boston University - 1/1/2015
• Introduction to Movement Disorders 
  Boston University - 1/1/2015
• Overview of Multiple Sclerosis 
  Boston University - 1/1/2015
• Medical Movement Disorders 
  Boston University - 1/1/2015
• Huntington Disease 
  Boston University - 1/1/2015
• How to Give a Presentation 
  Boston University - 1/1/2015
• Dystonia 
  Boston University - 1/1/2015
• Parkinson's Disease and Other Movement Disorders. 
  Metrowest Medical Center, Framingham, MA - 1/1/2015
• Adult Onset Neurological Diseases 
  Boston University - 1/1/2015
• Ask the Doctor 
  1/1/2014
• Neurological Emergencies 
  Boston University - 1/1/2014
• End Stage Huntington’s Disease. 
  Norwood, MA - 1/1/2013
• Practical Approach to Electromyography and Neuromuscular Disorders 2012 
  Boston University School of Medicine, Boston, Massachusetts - 9/28/2012
• Clinical Trials for National Youth Alliance, Ask the Expert: Neurologist, Clinical Trials 
  Las Vegas, NV - 1/1/2012
• Neurology in Primary Care: Headache, Dizziness and Tremor. 
  Boston University International Primary Care Training Institute, Boston, MA - 1/1/2011
• Internal Medicine Board Review – Neurology 
  Boston University - 1/1/2011
• Overview of Huntington’s disease. 
  Portsmouth, NH - 1/1/2010
• Clinical Research in Parkinson's Disease: Who Cares . . . and Why You Should. 
  Barnstable, MA, 2010; Jenks Senior Center, Winchester, MA, 2010 - 1/1/2010
• Progress in Parkinson’s Disease I: Clinical Research & the PPMI Study. 
  Sturbridge, MA - 1/1/2010
• Dementia and Dysphagia: Medical and Ethical Considerations 
  Boston University, Boston, MA - 1/1/2010
• Join now to see all

Other

• Are We Making Progress in the Management of Huntington Disease? 
  Frank S, Medscape video, CME
  1/16/2016
• Updates from Berlin: New Developments in Huntington's Disease. 
  Frank S, Vindico video, CME
  1/15/2016
• Parkinson’s Disease and Michael J. Fox Foundation study 
  Frank S, New England Cable News
  1/26/2014
• Parkinson’s Disease and Michael J. Fox Foundation study, pre-disease cohort. 
  Frank S, New England Cable News
  1/4/2013
• Sunday editorial and addressing questions about Parkinson’s disease. 
  Frank S, Boston Globe
  1/1/2011
• Parkinson's Disease and Michael J. Fox foundation and second appearance as commentary for gene transfer study 
  Frank S, Channel 5 News
  Boston, MA - 1/1/2011
• Cortico-basilar ganglionic degeneration 
  Frank S, MedLink
  1/1/2008
• Parkinson’s disease 
  Frank S, MedLink
  1/1/2008
• Pope John Paul II and Parkinson's Disease 
  Frank S, New England Cable News with Chet Curtis.
  1/1/2005
• Rating scales in Movement disorders 
  Frank S, MedLink
  1/1/2001
• Module 1: Natural History of HD and Introduction to Series 
  Frank S, HDSA CME – HD 101
• Module 10: Disability, Advocacy and Conclusions. 
  Frank S, HDSA CME – HD 101
• Join now to see all